Is there hope for spinal muscular atrophy synthetic pharmacotherapy?

Markus Riessland

doi:10.1080/14656566.2019.1595585

Is there hope for spinal muscular atrophy synthetic pharmacotherapy?

Markus Riessland

Neurobiology and Behavior

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	1049-1052
Number of pages	4
Journal	Expert Opinion on Pharmacotherapy
Volume	20
Issue number	9
DOIs	https://doi.org/10.1080/14656566.2019.1595585
State	Published - Jun 13 2019

Keywords

Antisense oligonucleotides (ASO)
nusinersen
spinal cord
spinal muscular atrophy
splicing correction therapy
survival of motor neuron (SMN2)

Access to Document

10.1080/14656566.2019.1595585

Cite this

@article{b48418270d564aa2998883df20e40dd7,

title = "Is there hope for spinal muscular atrophy synthetic pharmacotherapy?",

keywords = "Antisense oligonucleotides (ASO), nusinersen, spinal cord, spinal muscular atrophy, splicing correction therapy, survival of motor neuron (SMN2)",

author = "Markus Riessland",

year = "2019",

month = jun,

day = "13",

doi = "10.1080/14656566.2019.1595585",

language = "English",

volume = "20",

pages = "1049--1052",

journal = "Expert Opinion on Pharmacotherapy",